在Enterobacter cloacae复合体中,异质阻力是由短暂基因放大事件的变化引起的
Johannes Kupke1, Julian Brombach1, Yuwen Fang1
1Department of Veterinary Medicine, Institute of Microbiology and Epizootics, Centre for Infection Medicine, Freie Universität Berlin, Berlin, Germany.
npj antimicrobials and resistance
|February 22, 2025
概括
细菌中的异种电阻,在一些耐药细胞隐藏在易受感染的人群中,构成严重的治疗风险. 这项研究揭示了基因放大是推动这种危险现象的关键机制.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 异种耐药性 (HR) 是一种现象,在一个更大的易受感染人群中存在小小的抗生素耐药细菌亚群.
- 这种异质性可能导致治疗失败,如果不检测到耐药细胞.
研究的目的:
- 在临床Enterobacter cloacae复合体 (ECC) 菌株中研究塞夫塔齐 (CAZ) 异体抵抗的分子机制和表型特征.
- 了解HR在抗微生物治疗中的遗传基础和影响.
主要方法:
- 利用分子技术识别HR的遗传决定因素.
- 分析了细菌生长和耐药水平的表型变异.
- 在单细胞水平上研究基因拷贝数的变异.
主要成果:
- 确定了布拉达-1基因 (编码β-乳糖酶) 的等离子体传播基因重复放大 (GDA) 作为CAZ HR的主要驱动因素.
- 观察到各个殖民地GDA拷贝数的变化,与抵抗水平,滞后时间和生长率相关.
- 在单个耐药殖民地内证明了GDA异质性,表明单细胞水平的可塑性.
结论:
- 基因重复放大 (GDA) 是Enterobacter cloacae复合体中ceftazidime异阻力的关键机制.
- GDA的可塑性及其对细菌生长动态的影响凸显了误诊HR的重大风险.
- 无法检测HR可能导致随后的抗微生物治疗失败.
相关概念视频
01:33Bacterial Transformation
55.0K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.0K
00:57Antibiotic Selection
52.2K
Overview
52.2K